LIFECORE BIOMEDICAL, INC. DE - Common Stock, $0.001 par value per share (LFCR)

Historical Holders from Q1 2014 to Q1 2025

Symbol
LFCR on Nasdaq
CUSIP
514766104
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
36.9M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
23M
Holdings value
$171M
% of all portfolios
0.007%
Grand Portfolio weight change
+0%
Number of holders
74
Number of buys
39
Number of sells
-37
Average Value change %
+0%
Average buys %
+0.002%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LIFECORE BIOMEDICAL, INC. DE - Common Stock, $0.001 par value per share (LFCR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
22NW Fund, LP 11.1% $30.7M 4.37M 22NW Fund, LP Dec 23, 2024
Greenhaven Road Investment Management, L.P. 9.8% +25% $25.5M $8.79M 3.62M +52.8% Greenhaven Road Investment Management, L.P. Dec 31, 2024
David Capital Partners, LLC 4.87% $12.7M 1.8M David Capital Partners, LLC Dec 31, 2024

Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock, $0.001 par value per share (LFCR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 30.4K $214K -$380K $7.04 6
2024 Q4 23M $171M +$31.4M $7.43 74
2024 Q3 18.9M $93.3M +$965K $4.93 80
2024 Q2 18.6M $95.4M -$5.97M $5.13 74
2024 Q1 21.5M $114M +$1.26M $5.31 76
2023 Q4 21.2M $131M +$7.78M $6.19 77
2023 Q3 17.6M $132M -$4.24M $7.55 67
2023 Q2 18M $174M -$21.8M $9.67 73
2023 Q1 21.6M $81.7M -$20.9M $3.78 79
2022 Q4 24.7M $160M -$423K $6.48 90
2022 Q3 22.9M $204M -$4.23M $8.89 81
2022 Q2 24.5M $245M -$5.43M $9.97 84
2022 Q1 23.5M $272M -$4.46M $11.58 93
2021 Q4 25.3M $280M +$2.98M $11.10 93
2021 Q3 25.5M $235M +$6.26M $9.22 91
2021 Q2 25.3M $284M -$5.26M $11.25 92
2021 Q1 25.9M $274M -$6.65M $10.60 91
2020 Q4 26.5M $287M -$2.51M $10.85 94
2020 Q3 25.2M $245M +$4.94M $9.72 94
2020 Q2 23M $183M -$667K $7.96 87
2020 Q1 25.2M $219M -$4.61M $8.69 83
2019 Q4 27.1M $306M +$284K $11.31 92
2019 Q3 26.5M $287M -$10.5M $10.87 100
2019 Q2 27.5M $257M +$10M $9.37 95
2019 Q1 26.3M $323M +$1.99M $12.28 90
2018 Q4 25.9M $306M -$192K $11.84 88
2018 Q3 25.6M $366M -$3.19M $14.40 87
2018 Q2 24.5M $365M -$4.22M $14.90 88
2018 Q1 26.3M $343M +$5.88M $13.05 86
2017 Q4 25.1M $316M +$375K $12.60 86
2017 Q3 25.8M $334M +$6.01M $12.95 91
2017 Q2 25.3M $376M +$3.37M $14.85 93
2017 Q1 25.1M $301M +$27M $12.00 80
2016 Q4 24.6M $340M -$4.66M $13.80 90
2016 Q3 24.9M $334M -$7.76M $13.41 88
2016 Q2 25.5M $275M +$12.8M $10.76 89
2016 Q1 25M $263M +$7.1M $10.50 90
2015 Q4 24.4M $289M +$6.28M $11.83 106
2015 Q3 23.8M $277M -$6.5M $11.67 109
2015 Q2 23.9M $345M -$138K $14.43 106
2015 Q1 24M $335M +$730K $13.95 96
2014 Q4 24M $332M -$1.35M $13.81 103
2014 Q3 24.2M $294M +$2.43M $12.25 102
2014 Q2 23.9M $298M +$4.41M $12.49 98
2014 Q1 23.2M $259M -$9.17M $11.16 94